INFINITY PHRMA (NASDAQ:INFI)
5.95
0.3 (4.8%)
| INFINITY PHRMA (NASDAQ:INFI) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $6.25 | 52 Week High | $8.98 | ||
| Open | $6.20 | 52 Week Low | $4.77 | ||
| Day High | $6.27 | P/E | 4.34 | ||
| Day Low | $5.88 | EPS | $1.37 | ||
| Volume | 28,094 | ||||
| More INFI Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| DFR | 2 | ALTI | 1 |
| AXAS | 1 | DISH | 1 |
| HPT | 1 | NNI | 1 |
| SLW | 1 | VRNM | 1 |
| AGEN | 1 | CECE | 1 |
| ETE | 1 | KEYN | 1 |
Entities who have mentioned INFI
- Roth Capital | View Related Stories »
- Piper Jaffray | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- HSBC | View Related Stories »
- Trading Radar | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Lazard | View Related Stories »
- KeyBanc | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Credit Suisse | View Related Stories »
- Deutsche Bank | View Related Stories »
- Raymond James | View Related Stories »
- Wachovia | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- JPMorgan | View Related Stories »
StreetInsider.com Major News for INFI
View All ReportsStreetInsider.com Reports on INFI
- Infinity Pharma (INFI) Posts Q3 Loss of 36c, Beats Eatimates by 8c
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Morning Movers 5/29: INFI, JCG, CLDX, ODP, ALTI Higher; JMBA, ESL, WTSLA, CTAS, MENT Lower
- Infinity Pharma (INFI) Reports Recent Publication of New Scientific Paper Further Supporting Hedgehog Pathway Inhibitor
- Roth Downgrades Infinity Pharma (INFI) to Sell
View All Press ReleasesCompany Press Releases on INFI
- Infinity's IPI-504 Named One of Windhover and Campbell Alliance's "Top 10 Projects to Watch" in Oncology
- Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony
- Infinity to Present at Upcoming Conferences
- Infinity Reports Recent R&D Highlights and Third Quarter 2009 Results
- Infinity Announces Third Quarter 2009 Results Conference Call
StreetInsider Reports on INFI by Category
View All BlogsBlogs on INFI
- Nine Companies Added to Potential Activist Targets
- Bright Prospects for Micromet and Medimmune (Part 1)
- Bright Prospects for Micromet (Part 1)
- 20 'Bathwater Babies' and 15 'Dogs with Fleas' for the Week
- Analyst upgrades: INFI, LM and PNRA
View All FilingsSEC Filings on INFI
- Form 8-K INFINITY PHARMACEUTICALS For: Nov 16
- Form 10-Q INFINITY PHARMACEUTICALS For: Sep 30
- Form 8-K INFINITY PHARMACEUTICALS For: Nov 09
- Form 4 Lynch Thomas J. Jr. For: Oct 06
- Form 8-K INFINITY PHARMACEUTICALS For: Oct 06
Comments on INFI
No comments are currently available.
